Robert L JR Dixon
CIK 1524849 · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.80M
Companies
6
Total Filings
50
Lifetime Open-Market Net
-$2.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OKTA | Director | 13,956 | $136.21 | $1.90M | -$234.8K | 14 | 2026-06-22 |
| ELV | Director | 10,734 | $385.73 | $4.14M | -$363.0K | 7 | 2026-06-12 |
| BBW | Director | 48,428 | $35.31 | $1.71M | -$467.7K | 11 | 2024-06-17 |
| Elevance Health, Inc. (ANTM) Delisted | Director | 9,491 | $482.58 | $4.58M | -$1.14M | 9 | 2022-06-07 |
| ANTX | Director | 9,985 | $4.70 | $46.9K | $0 | 3 | 2017-05-22 |
| Elevance Health, Inc. (WLP) Delisted | Director | 4,929 | — | — | $0 | 2 | 2013-05-17 |
Recent Filings · Page 2 of 5
50 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-17 | ELV | Grant (A) | +388 | $0 | EDGAR |
| 2023-09-05 | BBW | Sell (S) | −8,076 | -$214.7K | EDGAR |
| 2023-09-01 | BBW | Notice (144) | −8,076 | -$213.0K | EDGAR |
| 2023-07-21 | ELV | Notice (144) | −310 | -$147.8K | EDGAR |
| 2023-07-21 | ELV | Sell (S) | −310 | -$147.8K | EDGAR |
| 2023-06-23 | OKTA | Mixed | +2,378 | $0 | EDGAR |
| 2023-06-12 | BBW | Grant (A) | +4,186 | $0 | EDGAR |
| 2023-05-12 | ELV | Grant (A) | +457 | $0 | EDGAR |
| 2022-09-12 | OKTA | Sell (S) | −400 | -$24.0K | EDGAR |
| 2022-06-23 | OKTA | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.